CN102448484A - 调节角质化细胞增生和分化的方法 - Google Patents

调节角质化细胞增生和分化的方法 Download PDF

Info

Publication number
CN102448484A
CN102448484A CN2010800240522A CN201080024052A CN102448484A CN 102448484 A CN102448484 A CN 102448484A CN 2010800240522 A CN2010800240522 A CN 2010800240522A CN 201080024052 A CN201080024052 A CN 201080024052A CN 102448484 A CN102448484 A CN 102448484A
Authority
CN
China
Prior art keywords
igfbp7
keratinocytes
expression
cells
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800240522A
Other languages
English (en)
Chinese (zh)
Inventor
埃利·施普雷舍尔
简纳·努斯贝克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rappaport Family Institute for Research in the Medical Sciences
Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical Center
Original Assignee
Rappaport Family Institute for Research in the Medical Sciences
Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rappaport Family Institute for Research in the Medical Sciences, Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical Center filed Critical Rappaport Family Institute for Research in the Medical Sciences
Publication of CN102448484A publication Critical patent/CN102448484A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CN2010800240522A 2009-04-01 2010-02-28 调节角质化细胞增生和分化的方法 Pending CN102448484A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20276009P 2009-04-01 2009-04-01
US61/202,760 2009-04-01
PCT/IL2010/000167 WO2010113146A1 (en) 2009-04-01 2010-02-28 A method of regulating proliferation and differentiation of keratinocyes

Publications (1)

Publication Number Publication Date
CN102448484A true CN102448484A (zh) 2012-05-09

Family

ID=42245610

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800240522A Pending CN102448484A (zh) 2009-04-01 2010-02-28 调节角质化细胞增生和分化的方法

Country Status (8)

Country Link
US (1) US8912142B2 (OSRAM)
EP (1) EP2344179A1 (OSRAM)
JP (1) JP2012522762A (OSRAM)
CN (1) CN102448484A (OSRAM)
AU (1) AU2010231514A1 (OSRAM)
CA (1) CA2759201A1 (OSRAM)
MX (1) MX2011010401A (OSRAM)
WO (1) WO2010113146A1 (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107881240A (zh) * 2017-12-27 2018-04-06 北京泱深生物信息技术有限公司 骨肉瘤的诊治标志物
CN109689867A (zh) * 2016-07-02 2019-04-26 富荣吉有限责任公司 利用基于肌动蛋白的肽调节细胞生物活性和细胞对胞内病原体易感性的组合物和方法
CN115212302A (zh) * 2022-08-03 2022-10-21 中国人民解放军空军军医大学 抗igfbp7抗体在治疗皮肤病中的应用

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102448484A (zh) 2009-04-01 2012-05-09 医学研究，基础设施和卫生服务基金的特拉维夫医疗中心 调节角质化细胞增生和分化的方法
US20130123647A1 (en) 2011-05-03 2013-05-16 The Research Foundation Of State University Of New York Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
US9687669B2 (en) 2011-11-09 2017-06-27 John Stephan Wearable light therapy apparatus
ES2676422T3 (es) * 2012-07-04 2018-07-19 Zz Biotech Llc Proteína C activada para su uso en el tratamiento de trastornos inflamatorios de la piel
DE102013213252A1 (de) * 2013-07-05 2015-01-08 Schülke & Mayr GmbH Verwendung eines Isopropanol enthaltenden Mittels zur Bekämpfung von Caliciviridae
KR20170023776A (ko) * 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
US20190083809A1 (en) 2016-07-27 2019-03-21 Z2020, Llc Componentry and devices for light therapy delivery and methods related thereto
US11147618B2 (en) 2017-01-11 2021-10-19 Medtronic Advanced Energy Llc Electrosurgical unit and system
GB201808723D0 (en) * 2018-05-29 2018-07-11 Univ Birmingham Treatment of hyperproliferative disorders
US12109253B2 (en) 2019-01-30 2024-10-08 Agency For Science, Technology And Research Use of IGFBP7 for treating malaria
WO2021113764A1 (en) * 2019-12-04 2021-06-10 Musc Foundation For Research Development Rnai-based targeting compounds and uses thereof to prevent acquired hearing loss
KR102453894B1 (ko) * 2020-09-15 2022-10-11 (주)아모레퍼시픽 캄페롤 배당체 화합물을 포함하는 피부 보호용 조성물
EP4454663A4 (en) * 2021-12-21 2026-04-08 Univ Tokyo THERAPEUTIC OR PROPHYLACTIC AGENT FOR HEART ATTACK, CARDIAC FIBROSIS OR HEART FAILURE, IN WHICH HTRA3 IS THE THERAPEUTIC TARGET

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1541107A (zh) * 2000-09-22 2004-10-27 ��ʿ����ѧ 生长因子复合物

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155591A (en) 1961-12-06 1964-11-03 Witco Chemical Corp Hair rinse compostions of polyoxypropylene quaternary ammonium compounds
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3959461A (en) 1974-05-28 1976-05-25 The United States Of America As Represented By The Secretary Of Agriculture Hair cream rinse formulations containing quaternary ammonium salts
US3929678A (en) 1974-08-01 1975-12-30 Procter & Gamble Detergent composition having enhanced particulate soil removal performance
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
LU76955A1 (OSRAM) 1977-03-15 1978-10-18
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4387090A (en) 1980-12-22 1983-06-07 The Procter & Gamble Company Hair conditioning compositions
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5151210A (en) 1985-07-25 1992-09-29 The Procter & Gamble Company Shampoo compositions
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5151209A (en) 1987-11-19 1992-09-29 The Procter & Gamble Company Shampoo compositions
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5011681A (en) 1989-10-11 1991-04-30 Richardson-Vicks, Inc. Facial cleansing compositions
US5120532A (en) 1990-04-06 1992-06-09 The Procter & Gamble Company Hair styling shampoos
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073372A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
JP2878528B2 (ja) 1992-07-21 1999-04-05 株式会社日立製作所 磁気記録再生装置
WO1994020063A2 (en) * 1993-03-04 1994-09-15 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
US5667487A (en) 1993-04-07 1997-09-16 Henley; Julian L. Ionosonic drug delivery apparatus
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US5807718A (en) 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
US5691380A (en) 1995-06-29 1997-11-25 The Procter & Gamble Company Stable n-acetylcysteine compositions and methods for treating human skin therewith
SK151599A3 (en) 1997-05-14 2000-09-12 Rhone Poulenc Rorer Pharma Peptide parathyroid hormone analogs
GB9811171D0 (en) 1998-05-22 1998-07-22 Royal Free Hosp School Med Viral vector
EP1082320A4 (en) * 1998-05-26 2001-11-21 Smithkline Beecham Corp NEW SUBSTITUTED IMIDAZOLE COMPOUNDS
CA2328457A1 (en) 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US7393548B2 (en) 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
AU2005316599A1 (en) * 2004-12-14 2006-06-22 Vertex Pharmaceuticals Incorporated Pyrimidine inhibitors of ERK protein kinase and uses therof
EP2332984A3 (en) 2005-09-30 2011-10-12 Universiteit Maastricht Tumor angiogenesis associated genes and a method for their identification
CA2999440C (en) 2007-09-11 2021-09-21 University Of Massachusetts Insulin-like growth factor binding protein 7 for treatment of cancer
CN102448484A (zh) 2009-04-01 2012-05-09 医学研究，基础设施和卫生服务基金的特拉维夫医疗中心 调节角质化细胞增生和分化的方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1541107A (zh) * 2000-09-22 2004-10-27 ��ʿ����ѧ 生长因子复合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J.SCHMITT,Z.ZHANG 等: "Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials", 《BRITISH JOURNAL OF DERMATOLOGY》 *
M.HOCHBERG,S.ZELIGSON 等: "Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding protein-7 after phototherapy", 《PHOTOBIOLOGY》 *
YOUNGMAN OH 等: "Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689867A (zh) * 2016-07-02 2019-04-26 富荣吉有限责任公司 利用基于肌动蛋白的肽调节细胞生物活性和细胞对胞内病原体易感性的组合物和方法
CN107881240A (zh) * 2017-12-27 2018-04-06 北京泱深生物信息技术有限公司 骨肉瘤的诊治标志物
CN107881240B (zh) * 2017-12-27 2018-10-02 北京泱深生物信息技术有限公司 骨肉瘤的诊治标志物
CN115212302A (zh) * 2022-08-03 2022-10-21 中国人民解放军空军军医大学 抗igfbp7抗体在治疗皮肤病中的应用

Also Published As

Publication number Publication date
EP2344179A1 (en) 2011-07-20
CA2759201A1 (en) 2010-10-07
MX2011010401A (es) 2012-01-20
US8912142B2 (en) 2014-12-16
WO2010113146A1 (en) 2010-10-07
AU2010231514A1 (en) 2011-11-03
US20110207665A1 (en) 2011-08-25
JP2012522762A (ja) 2012-09-27

Similar Documents

Publication Publication Date Title
US8912142B2 (en) Method of regulating proliferation and differentiation of keratinocyes
Ko et al. Mesenchymal stem and stromal cells harness macrophage-derived amphiregulin to maintain tissue homeostasis
Lumry et al. Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial
ES2973858T3 (es) Métodos para tratar infecciones cutáneas mediante la administración de un antagonista de IL-4R
Farrell et al. Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
AU2014274864B2 (en) Vitamin D receptor agonists to treat diseases involving CXCL12 activity
US20130266588A1 (en) Agents, Compositions, And Methods For Treating Pruritis And Related Skin Conditions
US8906875B2 (en) Methods of treating vascular inflammatory disorders
Shenoy et al. A closer look at the role of iron in glioblastoma
Bak et al. Protective effects of human umbilical cord blood-derived mesenchymal stem cells against dexamethasone-induced apoptotic cell death in hair follicles
Shibata et al. Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy
Kulshrestha et al. In vivo anti‐V‐ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses
Conte et al. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis
US11819535B2 (en) Composition and methods for regulating extracellular matrix accumulation
Wang et al. Rab GTPase 21 mediates caerulin-induced TRAF3-MKK3-p38 activation and acute pancreatitis response
Hou et al. Research on curcumin mediating immunotherapy of colorectal cancer by regulating cancer associated fibroblasts
Zhou et al. Trichosanthin-derived peptide Tk-PQ attenuates immune rejection in mouse tracheal allotransplant model by suppressing PI3K-Akt and inducing type II immune polarization
EP2649995A2 (en) Inhibition of post-radiation tumor growth
US20160022635A1 (en) Use of arginine vasopressin receptor antagonists for the treatment of prostate cancer
WO2016135732A1 (en) Method of promoting hair growth
Chen et al. The effect of Tocilizumab treatment for skin fibrosis by inhibiting CD38+ macrophages in systemic sclerosis
EP3621636B1 (en) Prevention and/or treatment of inflammatory skin disease
Barreto et al. Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice
US20060286117A1 (en) Neuronally expressed stem cell factor modulates angiogenesis and neural stem cell migration to areas of brain injury
US20220363776A1 (en) Methods and pharmaceutical composition for the treatment of ovarian cancer, breast cancer or pancreatic cancer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120509